Related Articles
Tranilast strongly sensitizes pancreatic cancer cells to gemcitabine via decreasing protein expression of ribonucleotide reductase 1
Prexasertib increases the sensitivity of pancreatic cancer cells to gemcitabine and S‑1
Establishment of human pancreatic cancer gemcitabine‑resistant cell line with ribonucleotide reductase overexpression
3F‑Box protein 32 degrades ataxia telangiectasia and Rad3‑related and regulates DNA damage response induced by gemcitabine in pancreatic cancer
CHK1 inhibition sensitizes pancreatic cancer cells to gemcitabine via promoting CDK-dependent DNA damage and ribonucleotide reductase downregulation